Modular Medical Announces Conference Call to Discuss FDA Approval of MODD1 Insulin Pump

SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the “Company” or “Modular Medical”) (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, easier to pay for and easier to use technology, today announced that it will host a conference call and webcast tomorrow, Thursday, September 5, 2024, at 8:30 a.m. Eastern Time to discuss the U.S. Food and Drug Administration (“FDA”) approval of its MODD1 pump, as well as next steps and milestones.

Information about conference calls and webcasts
Date: September 5, 2024
Time: 8:30am Eastern Time (5:30am Pacific Time)
Conference Call Number: 1-888-506-0062
International Calling Number: +1-973-528-0011
Access code: 914895
Webcast: Click here